1. CVS Health. Current and new approaches to making drugs more affordable. Updated August 2018. https://cvshealth.com/sites/default/files/cvs-health-current-and-new-approaches-to-making-drugs-more-affordable.pdf. Accessed 16 Feb 2019.
2. Institute for Clinical and Economic Review. The Institute for Clinical and Economic Review to Collaborate with the Department of Veteran Affairs’ Pharmacy Benefits Management Services Office. Updated June 27, 2017. https://icer-review.org/announcements/va-release/. Accessed 16 Feb 2019.
3. Robinson JC. Amgen Cuts Repatha’s Price By 60% Will Value-based Pricing Support Value-based Patient Access? Health Affairs. Updated November 28, 2018. https://www.healthaffairs.org/do/10.1377/hblog20181127.943927/full/. Accessed 16 Feb 2019.
4. Institute for Clinical and Economic Review. PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks. https://icer-review.org/material/high-cholesterol-final-report/. Accessed 20 Nov 2019.
5. Institute for Clinical and Economic Review. About. https://icer-review.org/about/. Accessed 16 Feb 2019.